Vaxcyte's total assets for Q1 2026 were $3.35B, an increase of 9.93% from the previous quarter. PCVX total liabilities were $352.29M for the fiscal quarter, a -2.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.